Roche aims to prove life-saving benefits of aleglitazar

pharmafile | June 10, 2009 | News story | Research and Development |  Roche, diabetes 

Related Content

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

alzheimers_brain

Roche receives CE Mark for blood test to help rule out Alzheimer’s

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

MetP Pharma releases positive data on intranasal semaglutide administration

MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering …

The Gateway to Local Adoption Series

Latest content